Delivery Order SPE2DB20D2104-SPE2DB25FMJSJ
Award Date
2/25/25
Potential Completion Date
2/26/25
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,025.46 firm fixed-price delivery order is for the supply of 100 count tablets of 27 mg methylphenidate extended-release, a medication commonly used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of May 9, 2024. AmerisourceBergen holds a $999,999,999...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,414.83, is for the delivery of 18 mg extended-release methylphenidate tablets, a medication commonly used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a period of performance through October 24, 2024 and is structured as a firm fixed-price...
This federal contract award, valued at $2,845.35, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 100 tablets of 36 mg Methylphenidate Extended Release, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract is a Firm Fixed Price Delivery Order with a completion date of February 5, 2025. The award is not associated with a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,681.22 firm-fixed-price delivery order is for the supply of 4,566,504,596 tablets of 27mg extended-release methylphenidate, a medication used to treat Attention Deficit Hyperactivity Disorder (ADHD). This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,102.66 firm-fixed-price delivery order is for the supply of 100 tablets of 27 mg Methylphenidate Extended-Release, a medication used to treat Attention Deficit Hyperactivity Disorder (ADHD). The contract has an ultimate completion date of September 17, 2024. AmerisourceBergen holds a significant $999,999,999...
This federal contract award, valued at $2,282.57, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 54mg methylphenidate extended-release tablets, a medication commonly used to treat attention-deficit/hyperactivity disorder (ADHD). The contract is structured as a delivery order and is priced on a firm-fixed-price basis. It does not have...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,533.72, is a Firm Fixed Price Delivery Order for the supply of 100 tablets of 54mg Methylphenidate Extended Release, a medication used to treat ADHD. The contract has an ultimate completion date of January 21, 2025. This award is not associated with a set-aside designation, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,245.77 firm fixed-price delivery order is for the supply of 4,566,735,446 tablets of 30mg extended-release methylphenidate, a medication used for the treatment of attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of December 17, 2024 and was awarded on December 16,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 18 mg Methylphenidate Extended-Release tablets, a medication used to treat Attention Deficit Hyperactivity Disorder (ADHD). The contract has a firm fixed price of $1,162.20 and a completion date of October 29, 2024. This award is a delivery order under a larger...
This federal contract award, valued at $5,417.40, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 54mg extended-release methylphenidate tablets, a medication commonly used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of November 6, 2024 and is structured as a Firm Fixed Price...